Recent News

• 06.12.2025 - Insmed Announces Pricing of $750 Million Public Offering of Common Stock
• 06.11.2025 - Insmed Announces Proposed $650 Million Public Offering of Common Stock
• 06.10.2025 - Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension
• 06.04.2025 - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Recent Filings

• 06.12.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2025 - 144 Report of proposed sale of securities
• 06.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 06.11.2025 - 144 Report of proposed sale of securities
• 06.10.2025 - EX-99.1 EX-99.1
• 06.10.2025 - 144 Report of proposed sale of securities
• 06.10.2025 - 144 Report of proposed sale of securities